Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / EPZM - Epizyme Inc. (EPZM) CEO Grant Bogle on Q1 2022 Results - Earnings Call Transcript

EPZM - Epizyme Inc. (EPZM) CEO Grant Bogle on Q1 2022 Results - Earnings Call Transcript

Epizyme Inc.
Epizyme, Inc. (EPZM) Q1 2022 Earnings Conference Call May 10, 2022, 08:30 AM ET Company Participants Grant Bogle – President and Chief Executive Officer Shefali Agarwal - Senior Medical Adviser, Interim Chief Medical and Development Officer Joe Beaulieu - Senior Vice President, Head of Finance Jerald Korn - Chief Operating Officer Conference Call Participants Peter Lawson - Barclays Peyton Bohnsack - Cowen Presentation Operator Hello, and welcome to Epizyme's First Quarter 2022 Financial Results Conference Call. At this time, all participants on a listen-only mode. Following the prepared remarks, there will be a question-and-answer session. Please be advised that this call is being recorded. I would now like to turn the call over to Kristen Hilton [ph] Investor Relations. You may begin. Unidentified Company Representative Thank you, operator. This morning, Epizyme issued a press release providing a business update in addition to first quarter 2022 financial results. The press release

For further details see:

Epizyme, Inc. (EPZM) CEO Grant Bogle on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Epizyme Inc.
Stock Symbol: EPZM
Market: NASDAQ
Website: epizyme.com
Menu
EPZM EPZM Quote EPZM Short EPZM News EPZM Articles EPZM Message Board
Get EPZM Alerts

News, Short Squeeze, Breakout and More Instantly...